Tigermed Reports Strong Financial Performance in 2025

Tigermed Consulting Co., Ltd., a leading provider of integrated research and development solutions, announced robust financial results for 2025. During the reporting period, the company achieved total revenue of RMB 6,833 million and a gross profit of RMB 1,873 million. Adjusted net profit attributable to the owners of the company stood at RMB 355 million. The segment revenue generated from Clinical Trial Solutions reached RMB 3,267 million, while that of Clinical-related and Lab Services hit RMB 3,566 million. China revenue accounted for 54% of total revenue, with overseas markets contributing 46%. Net new bookings in 2025 reached RMB 10,158 million,…